Abstract
A case of herpes simplex virus (HSV) meningitis complicated by ascending paralysis with almost complete recovery following antiviral treatment is reported. We present this case to illustrate the importance of including HSV-induced neuropathy in the differential diagnosis of acute neurologic symptoms following the viral illness.
Both types of herpes simplex virus (HSV) have been known to cause various neurologic syndromes, including meningitis (1–3). HSV-1 remains the most common cause of sporadic encephalitis, while HSV-2 infections of the central nervous system (CNS) mostly are restricted to aseptic meningitis. We report a case of HSV meningitis complicated by ascending paralysis caused by HSV to illustrate another neurological complication that can be treated with antiviral medication.
CASE DESCRIPTION
A 30-year-old African American woman presented to the emergency department (ED) with severe headache, fever (100.8°F oral), chills, photophobia, and tinnitus for 3 days preceded by several days of sore throat and nasal congestion. She was exposed to lead as a child and tested positive but never developed symptoms. She was cognitively intact. Her neck was markedly rigid. She had no skin or genital lesions. Her cranial nerves were intact. She ambulated to her car independently and without difficulty en route to the ED. She was admitted to the hospital and started on broad-spectrum antimicrobial coverage for suspected meningitis. Her initial workup at the ED and after admission is summarized in the Table. The cerebrospinal fluid (CSF) was positive for HSV by polymerase chain reaction with 540 viral copies/mL. A diagnosis of HSV meningitis was made, and antimicrobial coverage was narrowed to acyclovir.
Two days after admission, she developed bilateral lower-extremity weakness. She could barely break gravity on the left lower limb and could fight resistance briefly on the right side; she was weaker distally compared to proximally on both sides. Her bilateral deltoids were slightly weak, with full distal strength in the upper extremities. Her reflexes were brisk, including ankle jerks, and her toes were downgoing bilaterally. She had sensory loss to cold in her lower limbs to the knee with intact vibratory sensation. Within 2 weeks, the patient had significant improvement of weakness in the right lower extremity with complete return of sensation on that side. The left lower extremity, the more severely affected side, had only slight improvement in strength and had continued sensory deficits requiring inpatient rehabilitation.
A nerve conduction study (NCS) and electromyogram (EMG) 11 days after the onset of lower limb symptoms showed bilateral severe peroneal nerve axonal neuropathy, more marked distally and greater on the left than the right side. The remainder of the motor nerves tested (left median, left tibial, right tibial, and left ulnar) had velocities and amplitudes within the normal range. The F-waves were normally present in the left median and right tibial locations. EMG showed diffusely reduced recruitment in all muscles tested (left anterior tibialis, left gastrocnemius, left vastus lateralis, right anterior tibialis, and right gastrocnemius). A repeat NCS and EMG in the rehabilitation facility 35 days after symptom onset showed an overall improvement in amplitudes. She had a repeat CSF analysis for recurrent headache about 5 months after initial symptom onset, which was completely normal. One year after her initial presentation, she was fully ambulatory with rare sensation of tingling in her left leg. She was fatigued with prolonged exertion but did not require any assistive devices and had returned to work.
COMMENTS
Herpetic diseases were probably first described by Hippocrates (4). HSV-1 most commonly causes oral mucosal and facial skin lesions. HSV-2 is known for causing genital mucosal ulceration and is one of the most prevalent sexually transmitted infections worldwide. Persons with HSV-2 infection do not necessarily develop clinical disease, but most intermittently shed virus from the genital tract (5). The clinical manifestations of HSV infections are known to be diverse depending on the organ system afflicted. HSV establishes latency in sensory ganglia following initial acquisition, causing an infection that persists for life (6, 7). Both HSV-1 and HSV-2 have been associated with various neurologic syndromes, including meningitis (1–3). The CSF profile typically includes a lymphocytic pleocytosis, a normal CSF glucose concentration, and elevated protein. HSV DNA detection by polymerase chain reaction in the serum and/or CSF is the most sensitive and specific method for detecting HSV meningitis (8).
Patients with HSV meningitis can develop peripheral nerve involvement. HSV-1 has been implicated in at least one case of atypical lumbosacral pain, weakness in ankle dorsiflexion, and scattered hyperesthesia in L4 to S1 dermatomes unilaterally (2). Paresis of the bladder and anus, paresthesia of the buttocks and lower limbs, and symmetrical weakness in the lower limbs lasting 1 to 9 days (9) have been described with HSV-2. One year after HSV-2 infection, some patients developed paresis of the bladder and rectum as well as lower-extremity weakness even after clinical signs of meningitis had resolved. Given the array of neurological morbidities associated with HSV CNS infections, during the acute episode and following resolution, causes of acute neuropathies from HSV should be considered along with other more common entities, such as Guillain-Barré syndrome (GBS) (2, 4, 9–11).
Mononeuritis multiplex (MNM) is used to group multiple disorders with varying mechanisms of injury that cause damage to two or more separate peripheral nerves. MNM typically presents asymmetrically initially. It can become symmetrical with progression of the disease and can include damage to sensory, motor, and autonomic nerves (12). Causes of MNM include vasculitis, diabetes mellitus, amyloidosis, paraneoplastic syndromes, rheumatoid arthritis, and systemic lupus erythematosus.
Another consideration in our patient was GBS given the apparent ascending nature of the weakness. GBS can be protean in its presentation. Due to its multiple variants, GBS can simulate symptoms of other pathological conditions, making it difficult to reach a definitive diagnosis. The most common and classic description is the ascending paralysis seen in acute inflammatory demyelinating polyradiculoneuropathy. The disease is characterized by symmetrical weakness starting in the lower limbs, with or without sensory symptoms, progressing over hours or days to the upper body. Lower cranial nerves might be affected, leading to oropharyngeal dysphagia and respiratory failure. Sensory symptoms often include deep aching pain in weakened muscles, loss of proprioception, and areflexia (13). Acute motor and/or sensory axonal neuropathy are subtypes manifesting with motor and sensory symptoms with severe respiratory and bulbar involvement. Rarer subtypes include the Miller-Fisher variant, which presents with ophthalmoplegia, sensory ataxia, and areflexia. The pharyngeal-cervical-brachial variant presents with proximal descending weakness. In milder forms of the disease, only the cranial nerves might be affected (14). Acute pandysautonomia is another variant of GBS, which manifests with sympathetic and parasympathetic failure (13–15). GBS is often treated based on history and clinical examination. Spinal fluid and electrophysiological findings are corroborative, but often nondiagnostic. These tests may be limited because of the disease stage and presence of preexisting neuropathies.
Table.
Test | Result |
---|---|
Cerebrospinal fluid | |
Protein (mg/dL) | 237 |
Glucose (mg/dL) | 52 |
White blood cells (per µL) | 975 (62% lymphocytes) |
Gram stain | Negative |
HSV PCR (copies/mL) | 540 |
West Nile virus Ab | Negative |
VDRL | Negative |
Other labs | Negative for adenovirus, Epstein-Barr virus, varicella-zoster virus, coxsackie Ab, cytomegalovirus, cryptococcal antigen |
Blood | |
White blood cells (per µL) | 14,800 |
Blood culture | No growth |
HIV | Negative |
Rapid plasma reagin | Negative |
HHV6 PCR | Negative |
Mycoplasma IgM | Negative |
Lyme Ab | Negative |
Monospot | Negative |
TSH/Folate/B12 | Within normal limits |
Urine protein electrophoresis | Negative |
Serum protein electrophoresis | Negative |
Heavy metal screen | Negative |
24-hr urine lead | Negative |
Imaging | |
CT scan head | Normal with possible maxillary sinuses |
MRI brain/spine with contrast | No acute abnormalities |
Ab indicates antibody; CT, computed tomography; HHV6, human herpesvirus 6; HSV, herpes simplex virus; MRI, magnetic resonance imaging; PCR, polymerase chain reaction; TSH, thyroid-stimulating hormone; VDRL, Venereal Disease Research Laboratory test.
References
- 1.Morrison RE, Miller MH, Lyon LW, Griffiss JM, Artenstein MS. Adult meningoencephalitis caused by herpesvirus hominis type 2. Am J Med. 1974;56(4):540–544. doi: 10.1016/0002-9343(74)90486-0. [DOI] [PubMed] [Google Scholar]
- 2.Morrison RE, Shatsky SA, Holmes GE, Top FH, Jr, Martins AN. Herpes simplex virus type I from a patient with radiculoneuropathy. JAMA. 1979;241(4):393–394. [PubMed] [Google Scholar]
- 3.Terni M, Caccialanza P, Cassai E, Kieff E. Aseptic meningitis in association with herpes progenitalis. N Engl J Med. 1971;285(9):503–504. doi: 10.1056/NEJM197108262850908. [DOI] [PubMed] [Google Scholar]
- 4.Kleinschmidt-DeMasters BK, Gilden DH. The expanding spectrum of herpesvirus infections of the nervous system. Brain Pathol. 2001;11(4):440–451. doi: 10.1111/j.1750-3639.2001.tb00413.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest. 1997;99(5):1092–1097. doi: 10.1172/JCI119237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Dowdle WR, Nahmias AJ, Harwell RW, Pauls FP. Association of antigenic type of herpesvirus hominis with site of viral recovery. J Immunol. 1967;99(5):974–980. [PubMed] [Google Scholar]
- 7.Nahmias AJ, Roizman B. Infection with herpes-simplex viruses 1 and 2. 1. N Engl J Med. 1973;289(13):667–674. doi: 10.1056/NEJM197309272891305. [DOI] [PubMed] [Google Scholar]
- 8.Klapper PE, Cleator GM, Dennett C, Lewis AG. Diagnosis of herpes encephalitis via Southern blotting of cerebrospinal fluid DNA amplified by polymerase chain reaction. J Med Virol. 1990;32(4):261–264. doi: 10.1002/jmv.1890320413. [DOI] [PubMed] [Google Scholar]
- 9.Aurelius E, Forsgren M, Gille E, Sköldenberg B. Neurologic morbidity after herpes simplex virus type 2 meningitis: a retrospective study of 40 patients. Scand J Infect Dis. 2002;34(4):278–283. doi: 10.1080/00365540110080485. [DOI] [PubMed] [Google Scholar]
- 10.Sasadeusz JJ, Sacks SL. Herpes latency, meningitis, radiculomyelopathy and disseminated infection. Genitourin Med. 1994;70(6):369–377. doi: 10.1136/sti.70.6.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Berger JR, Houff S. Neurological complications of herpes simplex virus type 2 infection. Arch Neurol. 2008;65(5):596–600. doi: 10.1001/archneur.65.5.596. [DOI] [PubMed] [Google Scholar]
- 12.Vial C, Bouhour F. Vasculitis multiple mononeuropathies. Rev Prat. 2008;58(17):1896–1899. [PubMed] [Google Scholar]
- 13.Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005;366(9497):1653–1666. doi: 10.1016/S0140-6736(05)67665-9. [DOI] [PubMed] [Google Scholar]
- 14.Hahn AF. Guillain-Barré syndrome. Lancet. 1998;352(9128):635–641. doi: 10.1016/S0140-6736(97)12308-X. [DOI] [PubMed] [Google Scholar]
- 15.Akbayram S, Doğan M, Akgün C, Peker E, Sayιn R, Aktar F, Bektas MS, Caksen H. Clinical features and prognosis with Guillain-Barré syndrome. Ann Indian Acad Neurol. 2011;14(2):98–102. doi: 10.4103/0972-2327.82793. [DOI] [PMC free article] [PubMed] [Google Scholar]